|
C14ORF143 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.99904545641994E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.78680428628309E-11 |
| Normal-vs-Stage2 |
6.08859999999822E-05 |
| Normal-vs-Stage3 |
2.69989997025988E-09 |
| Normal-vs-Stage4 |
1.02459996043081E-09 |
| Stage1-vs-Stage2 |
6.394600E-01 |
| Stage1-vs-Stage3 |
7.633200E-01 |
| Stage1-vs-Stage4 |
7.773600E-02 |
| Stage2-vs-Stage3 |
5.367000E-01 |
| Stage2-vs-Stage4 |
9.522000E-02 |
| Stage3-vs-Stage4 |
1.437400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.29880567306873E-12 |
| Normal-vs-AfricanAmerican |
4.583300E-03 |
| Normal-vs-Asian |
8.60940000402266E-08 |
| Caucasian-vs-AfricanAmerican |
2.320400E-01 |
| Caucasian-vs-Asian |
7.637800E-01 |
| AfricanAmerican-vs-Asian |
2.562400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.54359866502796E-11 |
| Normal-vs-Female |
5.41220401828468E-11 |
| Male-vs-Female |
1.413640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.12090001117105E-09 |
| Normal-vs-Age(41-60Yrs) |
2.55159999795751E-08 |
| Normal-vs-Age(61-80Yrs) |
4.1925000138221E-09 |
| Normal-vs-Age(81-100Yrs) |
3.138400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.571200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.882600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.897000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.541400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.226200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.103200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.716100E-02 |
| Classical-VS-Follicular |
1.301270E-03 |
| Classical-VS-Other |
2.100400E-01 |
| Classical-VS-Normal |
1.25940002870806E-09 |
| Tall-VS-Follicular |
4.686600E-01 |
| Tall-VS-Other |
5.441400E-01 |
| Tall-VS-Normal |
7.34139999902794E-08 |
| Follicular-VS-Other |
8.914000E-01 |
| Follicular-VS-Normal |
1.2646994562715E-10 |
| Other-VS-Normal |
2.461900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.89129950484346E-10 |
| Normal-vs-N1 |
1.11400000002426E-07 |
| N0-vs-N1 |
4.089200E-01 |
|
|
